More importantly, our study also showed that over-expression of PTBP1 was correlated with poor DFS with stage II (without lymph node metastasis) and stage III patients (with lymph node metastasis), respectively and independently (Figure 1B). Here, PTBP1 is linked to metastatic malignant neoplasm in the lymph nodes.